Original Article

Antileishmanial Activity of Manganese (III) Oxide Nanoparticles (Mn2O3 NPs) Alone and in Combination with Shark Cartilage Extract against Leishmania infantum: in Vitro and in Vivo Approaches

Abstract

Background: The recent increase in unresponsive cases to current treatments poses a significant challenge in the effort to discover new antileishmanial drugs. We aimed to investigate the effects of Mn2O3 NPs alone or in combination with shark cartilage extract (ShCE) on L. infantum (MCAN/ES198/LIM-877) both in vitro and in vivo.

Methods: The susceptibility of promastigotes and amastigotes was evaluated using MTT and microscopy assays with different concentrations of Mn2O3 NPs alone or in combination with ShCE (Mn2O3-ShCE). The combination index (CI) was used to assess potential synergy. Cytotoxicity against J774.A1 macrophages was measured, and the selectivity index (SI) was calculated. Also, apoptosis was analyzed in promastigotes. The therapeutic and prophylactic effects were tested in BALB/c mice, and survival rates were monitored.

Results: Mn2O3 NPs caused a dose-dependent decrease in proliferation of promastigotes (IC50=19.8±1.1 μg/mL) and amastigotes (IC50=29.9±0.05 μg/mL). Co‑treatment with ShCE significantly enhanced the antileishmanial activity, reducing the IC50 values of promastigotes and amastigotes. The CC50 values were 159.9±4.2 μg/mL for Mn2O3 NPs and 276.5±7.9 μg/mL for Mn2O3-ShCE. Apoptosis rates in promastigotes treated with Mn2O3 and Mn2O3-ShCE were 80.7% and 86.3%, respectively. Parasite loads in the tissues significantly decreased (P<0.001) in BALB/c mice treated with Mn2O3 NPs, and survival rates increased significantly (P<0.05). The combination with ShCE further improved outcomes, with 100% survival observed in the Mn2O3-ShCE group (P<0.01).

Conclusion: These findings demonstrated a synergistic effect between Mn2O3 NPs and ShCE against L. infantum. Therefore, it may serve as a promising candidate for future development of leishmanicidal drugs.

1. Aryal S, Chauhan U, Pokhrel S. Leishmaniasis: Global Epidemiology, Transmission Dynamics, and Integrated Control Strategies. Int J Trop Dis Health. 2025;46(7):93-109.
2. Ferreira BA, Coser EM, de la Roca S, et al. Amphotericin B resistance in Leishmania amazonensis: In vitro and in vivo characterization of a Brazilian clinical isolate. PLoS Negl Trop Dis. 2024;18(5):e0012175.
3. Gebremichael Tedla D, Bariagabr FH, Abreha HH. Incidence and Trends of Leishmaniasis and Its Risk Factors in Humera, Western Tigray. J Parasitol Res. 2018; 2018:8463097.
4. Freitas CS, Lage DP, Machado AS, et al. Exploring drug repositioning for leishmaniasis treatment: Ivermectin plus polymeric micelles induce immunological response and protection against tegumentary leishmaniasis. Cytokine. 2023; 164:156143.
5. Akbari M, Oryan A, Hatam G. Application of nanotechnology in treatment of leishmaniasis: A Review. Acta Trop. 2017; 172:86-90.
6. Guerra RO, do Carmo Neto JR, et al. Metallic Nanoparticles: A New Frontier in the Fight Against Leishmaniasis. Curr Med Chem. 2022;29(26):4547-4573.
7. Tavakoli P, Ghaffarifar F, Delavari H, et al. Efficacy of manganese oxide (Mn2O3) nanoparticles against Leishmania major in vitro and in vivo. J Trace Elem Med Biol. 2019; 56:162-8.
8. Ejazi SA, Satoskar A, Singh N. Editorial: Leishmaniasis and immunity: challenges, advances and future perspective. Front Immunol. 2025;16:1666020.
9. Molaie S, Ghaffarifar F, Dalimi A, et al. Evaluation of synergistic therapeutic effect of shark cartilage extract with artemisinin and glucantime on visceral leishmaniasis in BALB/c mice. Iran J Basic Med Sci. 2019;22(2):146-153.
10. Costa-Madeira JC, Trindade GB, Almeida PHP, et al. T Lymphocyte Exhaustion During Human and Experimental Visceral Leishmaniasis. Front Immunol. 2022; 13:835711.
11. Safari E, Hassan ZM. Immunomodulatory effects of shark cartilage: Stimulatory or anti-inflammatory. Process Biochemistry. 2020; 92:417-25.
12. Ghafarifar F, Molaie S, Abazari R, et al. Fe3O4@ Bio-MOF nanoparticles combined with artemisinin, glucantime®, or shark cartilage extract on Iranian strain of leishmania major (MRHO/IR/75/ER): An in-vitro and in-vivo study. Iran J Parasitol. 2020;15(4):537-548.
13. Martin L, Lopez K, Fritz S, et al. Determination of the optical interference of iron oxide nanoparticles in fluorometric cytotoxicity assays. Heliyon. 2024; 10(3):e25378.
14. Saraei S, Soozangar N, Miran M, et al. In vitro Evaluation of the Potent Antileishmanial Activity of Ferula tabasensis alone or in Combination with Shark Cartilage Extract Against the Standard Iranian Strain of Leishmania major (MRHO/IR/75/ER). Iran J Pharm Res. 2023;22(1):e136173.
15. Oliveira-Ribeiro C, Pimentel MIF, Oliveira LFA, et al. An old drug and different ways to treat cutaneous leishmaniasis: Intralesional and intramuscular meglumine antimoniate in a reference center, Rio de Janeiro, Brazil. PLoS Negl Trop Dis. 2021;15(9):e0009734.
16. Anber AA, Hameed AS, Rheima AM, et al. Rapid sustainable synthesis of Mn2O3, CuO, and binary CuO/Mn2O3 nanoparticles using continuous laser diode for enhanced antibacterial strategy against resistant pathogens. Case Stud Chem Environ Eng. 2024; 10:101003.
17. Jamshaid H, Din FU, Khan GM. Nanotechnology based solutions for anti-leishmanial impediments: a detailed insight. J Nanobiotechnology. 2021;19(1):106.
18. Narayan S. A comprehensive review of manganese dioxide nanoparticles and strategy to overcome toxicity. Nanomed J. 2023;10(1):1-15.
19. da Silva F, Rizk YS, das Neves AR, et al. Antileishmanial Activity, Toxicity and Mechanism of Action of Complexes of Sodium Usnate with Lanthanide Ions: Eu(III), Sm(III), Gd(III), Nd(III), La(III) and Tb(III). Int J Mol Sci. 2023; 25(1):413.
20. Bastos DS, Silva AC, Novaes RD, et al. Could combination chemotherapy be more effective than monotherapy in the treatment of visceral leishmaniasis? A systematic review of preclinical evidence. Parasitology. 2022; 1-14.
21. Mousavi P, Zolfaghari A, Aghaei M, et al. Combination Therapy for the Treatment of Cutaneous Leishmaniasis Compared with Standard Drugs, In Vitro or In Vivo: A Systematic Review. Adv Biomed Res. 2025;14:131.
22. Adil M, Al-Khalidi A, Hamad AK, et al. The Efficacy of Manganese Oxide (Mn2O3) Nanoparticles and Tellurium Oxide (TeO2) Nanorods Against Leishmania Lesions in Female Albino Rats. J Nanostruct. 2023;13(2):390-396.
23. Brígido HPC, Dos Santos LGA, de Barros RC, et al. The Role of Oxidative Stress in the Pathogenesis and Treatment of Leishmaniasis: Impact on Drug Toxicity and Therapeutic Potential of Natural Products. Toxics. 2025;13(3):190.
24. Shoshin DE, Sizova EA, Kamirova AM. Morphological changes and luminescence of Escherichia coli in contact with Mn2O3 and Co3O4 ultrafine particles as components of a mineral feed additive. Vet World. 2024;17(8):1880-1888.
25. Elikaee S, Taylor JK, Carter NS, et al. Biogenically Synthesized Nanoparticles as Emerging Therapeutics for Leishmaniasis: A Review of Recent Advances and Potential Promises. Int J Nanomedicine. 2025; 20:12467-12484.
26. Nafari A, Cheraghipour K, Sepahvand M, et al. Nanoparticles: New agents toward treatment of leishmaniasis. Parasite Epidemiol Control. 2020;10:e00156.
27. Garg R, Singh N, Dube A. Intake of nutrient supplements affects multiplication of Leishmania donovani in hamsters. Parasitology. 2004; 129(Pt 6):685-91.
Files
IssueVol 21 No 2 (2026) QRcode
SectionOriginal Article(s)
Keywords
Mn2O3 NPs Shark cartilage extract Leishmania infantum In vitro In vivo
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Mashhadi Z, Ziyabakhsh A, Farrokhiasl N, Ghaffarifar F, Mohammadi-Ghalehbin B, Asfaram S, Molaei S. Antileishmanial Activity of Manganese (III) Oxide Nanoparticles (Mn2O3 NPs) Alone and in Combination with Shark Cartilage Extract against Leishmania infantum: in Vitro and in Vivo Approaches. Iran J Parasitol. 2026;21(2):275-286.